The High Rate of Readmissions Among Patients With Heart Failure

The High Rate of Readmissions Among Patients With Heart Failure

The High Rate of Readmissions Among Patients With Heart Failure

Assessing the Problem

The high risk of readmission among heart failure patients has been noted as an issue. Care quality, patient safety, and healthcare system and individual costs will all be evaluated as a result of this analysis. My practicum patient was a 65-year-old woman called Mei Lee, she was suffering from heart failure. To supplement my research, I spoke with authorities in the field and relevant industries. I was concerned about Mei Lee’s heart failure and wanted to know whether she or her loved ones had ever been in any dangerous situations because of it. This aids in pinpointing any possible damage or negative repercussions brought on by the issue. Mei Lee said she had fallen several times at home due to her dizziness and weakness as a result of her heart failure. These safety incidents call attention to the necessity for efficient management and measures to forestall future damage.

Patient safety, quality of treatment, and healthcare expenditures are all negatively affected by the high number of readmissions, which I explained to Mei Lee during our initial appointment. Disquietude, fever, chills, unbending nature, hack, dyspnea, and chest uneasiness are some disease-related side effects patients report encountering. When the finding was considered in light of the patient’s clinical presentation and chest imaging, a blood culture or bronchoscopy examination of the lower respiratory tract was utilized to affirm the determination. The general forecast was terrible, and comorbidities contributed to this.

Lacking consideration of Mei Lee’s cardiovascular breakdown, which brings about intensifications and readmissions, is demonstrated by her continuous visits to the crisis division (ED) and her set of experiences of hospitalizations. She is currently taking different medications, like diuretics, beta-blockers, and ACE inhibitors, and the majority of them are covered by her protection. Discombobulation and fatigue are two antagonistic impacts that Mei Lee experiences intermittently, highlighting the requirement for careful observation and treatment of her condition. In addition to that, she sees her primary care physician once per month and participates in cardiac rehabilitation classes twice weekly. Because of these frequent visits and treatments, she must have continued monitoring, support, and follow-up care to manage her heart failure best. The coverage that Mei Lee has for her insurance makes it possible for her to finance necessary therapies and gives her access to them.

My Experience with the Patient

During the first two hours of my practicum, I examined the patient’s medical condition. I also conferred with authorities on the subject and the relevant industry to acquire further information. Mei Lee admitted the existence and gravity of the issue during their consultation. She was worried that her health, happiness, and healthcare bills would all suffer due to her repeated hospitalizations. She felt that reducing the high incidence of readmissions among heart failure patients was crucial to increase patient safety, boosting treatment quality, and decreasing healthcare costs. I spoke with patients and looked at evidence-based practice publications and websites to learn more about the extent of the issue. High readmission rates have been linked to higher morbidity, death, and healthcare expenditures for heart failure patients, as reported by these sources. The data showed that specific measures were needed to lower readmission rates and improve patient health outcomes.

Evidence-Based Practise Review

As part of my research, I reviewed several crucial evidence-based practices (EBP) documents and websites, such as those from the National Institutes of Health and Biomed Central, which discussed Heart Failure in healthcare facilities. These materials were beneficial because they detailed effective preventative measures, treatment protocols, and evidence-based interventions. One of the most common reasons for both first and subsequent hospital stays is heart failure (HF). Clinicians, researchers, and other stakeholders are emphasizing reducing readmissions among HF patients (Wang et al., 2022). Despite the widespread availability of evidence-based treatments for managing HF, there is room for advancement regarding the reliability of these therapies and the efficacy of newly developed techniques for preventing readmissions.

As per the research, in 2010, an estimated 1 million people were released from the hospital with HF as their primary diagnosis. In 2012, HF cost a total of $30.7 billion. Medicare reports that the median risk-standardized 30-day readmission rate for HF was 23.0% between 2009 and 2012 (Ziaeian & Fonarow, 2019). Researchers and policyma